Topcon Healthcare, Inc. appoints Krysten Williams Head of Digital Solutions & Clinical Development – EMEA

News
Article

Williams joins Topcon Healthcare from Heidelberg Engineering, where she held multiple senior leadership roles.

Image credit: AdobeStock/AmCollection

(Image credit: AdobeStock/AmCollection)

Topcon Healthcare, Inc. has appointed Krysten Williams as Head of Digital Solutions & Clinical Development – EMEA. The company stated that, in this role, Williams is set to lead the expansion of the company’s digital innovation strategy across Europe, guide development of new solutions that align with the company’s Healthcare from the Eye initiative, and foster a connected care model that uses ocular imaging and artificial intelligence (AI), power ocular imaging or functional data to detect, and manage both ocular and systemic diseases.1

In the press release1 Ali Tafreshi, CEO & President of Topcon Healthcare, shared his thoughts on this appointment, saying, “Krysten is a dynamic, forward-thinking leader who brings deep expertise in imaging, software, and commercialization across the global eye care and digital health landscape. Her ability to translate clinical innovation into scalable solutions will be pivotal as we expand our Healthcare from the Eye ecosystem across Europe and the broader healthcare landscape.”

Williams joins Topcon Healthcare from Heidelberg Engineering, where she held multiple senior leadership roles, including Head of Global Marketing and Education, Head of Product Management and Clinical Affairs, and Managing Director of Heidelberg Engineering Ltd. Her career has focused on empowering eye care professionals to improve patient care by delivering digital healthcare solutions in retail practice, clinic and scientific research.1

The press release1 issued by Topcon also includes a quote from Williams sharing her feelings on this new role. She said, “I’m honored to join Topcon Healthcare at a time of meaningful transformation in digital health. The opportunity to help shape solutions that use the eye to deliver earlier, more personalized care is truly exciting. I look forward to working with the team to drive innovation that benefits both clinicians and patients.”

With this appointment, Topcon Healthcare, Inc. feels that the company strengthens its commitment to innovative leadership in Europe and globally.1

Reference:
1. Topcon Healthcare, Inc. Appoints Krysten Williams as Head of Digital Health Solutions & Clinical Development – EMEA. Topcon Healthcare, Inc. May 8, 2025. Accessed May 8, 2025. https://topconhealthcare.com/article/topcon-healthcare-inc-appoints-krysten-williams-as-head-of-digital-health-solutions-clinical-development-emea/

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.